Table 3.

Difference in variables monitored for safety comparing changes in intervention groups to controls.

Variable	Comparison to control	Difference from control	Lower CI	Upper CI	p‐value
Ferritin	Low dose	−3.81490	−16.34835	8.71855	0.55
	High dose	2.04698	−12.58993	16.68390	0.78
	Combined	−2.87468	−13.32473	2.41211	0.17
SGOT (AST)	Low dose	−0.13765	−1.83465	1.55936	0.87
	High dose	0.54273	−1.29963	2.38509	0.56
	Combined	−2.87468	−13.32473	2.41211	0.17
SGPT (ALT)	Low dose	0.01020	−2.23043	2.25082	0.99
	High dose	0.52793	−2.16559	3.22145	0.70
	Combined	0.30946	−1.16909	1.59628	0.76
Creatinine	Low dose	−0.02761	−0.06993	0.01472	0.20
	High dose	0.00303	−0.04404	0.05011	0.90
	Combined	−0.01705	−0.02944	0.01390	0.48
Hemoglobin	Low dose	−0.27376	−0.49929	−0.04824	0.02
	High dose	−0.20988	−0.42637	0.00662	0.057
	Combined	−0.23517	0.01420	0.24406	0.03

Comparisons of week 8 to baseline values (12 weeks).